SAM
TEVA icon

Strategy Asset Managers’s Teva Pharmaceuticals TEVA Stock Holding History

Strategy Asset Managers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-210,973
Closed -$7.01M – 145
2017
Q2 		$7.01M Buy
210,973
+29,526
+16% +$914K 1.44% 26
2017
Q1 		$5.82M Buy
181,447
+7,269
+4% +$248K 1.26% 29
2016
Q4 		$6.01M Buy
174,178
+17,035
+11% +$680K 1.32% 29
2016
Q3 		$7.23M Buy
157,143
+112
+0.1% +$5.84K 1.62% 26
2016
Q2 		$7.89M Buy
157,031
+1,686
+1% +$89.8K 1.79% 24
2016
Q1 		$8.31M Sell
155,345
-9,197
-6% -$540K 1.89% 21
2015
Q4 		$10.8M Sell
164,542
-4,702
-3% -$291K 2.46% 9
2015
Q3 		$9.56M Sell
169,244
-3,061
-2% -$198K 2.29% 13
2015
Q2 		$10.2M Sell
172,305
-3,922
-2% -$242K 2.27% 14
2015
Q1 		$11M Sell
176,227
-9,287
-5% -$540K 2.4% 8
2014
Q4 		$10.7M Sell
185,514
-2,877
-2% -$160K 2.24% 13
2014
Q3 		$10.1M Buy
188,391
+227
+0.1% +$12K 2.21% 15
2014
Q2 		$9.86M Sell
188,164
-2,347
-1% -$120K 2.1% 19
2014
Q1 		$10.1M Buy
190,511
+3,585
+2% +$166K 2.17% 16
2013
Q4 		$7.49M Buy
186,926
+4,586
+3% +$181K 1.64% 26
2013
Q3 		$6.89M Buy
182,340
+2,401
+1% +$93.7K 1.63% 26
2013
Q2 		$7.05M Buy
+179,939
New +$7.01M 1.68% 25

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Strategy Asset Managers's TEVA Position: Q3 2017 in Review

Strategy Asset Managers sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 210,973 shares — an estimated $7.01M sold.

Strategy Asset Managers first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $11M in Q1 2015. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Strategy Asset Managers reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Strategy Asset Managers sold 210,973 Teva Pharmaceuticals shares in Q3 2017, an estimated $7.01M.
  • Strategy Asset Managers first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Strategy Asset Managers's Teva Pharmaceuticals position peaked at $11M in Q1 2015.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Strategy Asset Managers's 13F filing for Q3 2017, filed 6 Nov 2017.